Get the Stockscreener App
3.90
9.55%
0.34
After Hours:
3.92
0.02
+0.51%
Arq Inc stock is traded at $3.90, with a volume of 246.59K.
It is up +9.55% in the last 24 hours and up +5.12% over the past month.
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.
See More
Previous Close:
$3.56
Open:
$3.53
24h Volume:
246.59K
Relative Volume:
0.93
Market Cap:
$178.57M
Revenue:
$99.18M
Net Income/Loss:
$-12.25M
P/E Ratio:
-8.4783
EPS:
-0.46
Net Cash Flow:
$-44.17M
1W Performance:
-7.80%
1M Performance:
+5.12%
6M Performance:
-43.64%
1Y Performance:
-48.68%
1-Day Range:
$3.53
$3.915
1-Week Range:
$3.39
$4.40
52-Week Range:
$3.34
$8.11
Arq Inc Stock (ARQ) Company Profile
Name
Arq Inc
Sector
Industry
Phone
720-598-3500
Address
8051 E. MAPLEWOOD AVE., STE 210, GREENWOOD VILLAGE
Compare ARQ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARQ
Arq Inc
|
3.90 | 178.57M | 99.18M | -12.25M | -44.17M | -0.46 |
|
VLTO
Veralto Corp
|
97.06 | 23.68B | 5.19B | 833.00M | 820.00M | 3.34 |
|
ZWS
Zurn Elkay Water Solutions Corp
|
35.20 | 5.88B | 1.55B | 137.70M | 270.00M | 0.79 |
|
FSS
Federal Signal Corp
|
89.56 | 5.28B | 1.86B | 216.30M | 190.70M | 3.50 |
|
ATMU
Atmus Filtration Technologies Inc
|
36.27 | 2.98B | 1.66B | 180.30M | 72.30M | 2.15 |
|
PCT
Purecycle Technologies Inc
|
7.29 | 1.21B | 0 | -153.12M | -188.47M | -0.9305 |
Arq Inc Stock (ARQ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-19-24 | Initiated | Canaccord Genuity | Buy |
| Feb-06-17 | Initiated | Rodman & Renshaw | Buy |
Arq Inc Stock (ARQ) Latest News
Canaccord Genuity Group Lowers ARQ (NASDAQ:ARQ) Price Target to $8.00 - Defense World
Analysts Issue Forecasts for ARQ’s Q2 Earnings (NASDAQ:ARQ) - Defense World
Arq outlines GAC production ramp-up timeline amid robust PAC performance - MSN
Optimistic Buy Rating for Arq Inc Despite GAC Facility Delays, Supported by Strong PAC Performance and Favorable Regulatory Outlook - TipRanks
Quarterly Metrics: Quick and Current Ratios for Arq Inc (ARQ) - DWinneX
Arq stock price target cut to $8 by Canaccord Genuity - Investing.com India
Arq: Granular Activated Carbon Project Suffers Further DelaysHold - Seeking Alpha
Arq Inc earnings beat by $0.05, revenue topped estimates - Investing.com India
Transcript : Arq, Inc., Q1 2025 Earnings Call, May 07, 2025 - marketscreener.com
Arq Q1 2025 presentation: Revenue up 25%, GAC production timeline extended - Investing.com
Earnings call transcript: Arq Inc’s Q1 2025 results show growth amid challenges - Investing.com
Arq, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Arq, Inc. (ARQ) Reports Break-Even Earnings for Q1 - Yahoo Finance
Arq, Inc. Reports First Quarter 2025 Results - TradingView
Arq, Inc. SEC 10-Q Report - TradingView
Arq Reports First Quarter 2025 Results - GlobeNewswire
Arq to Host First Quarter 2025 Conference Call on May 7, 2025 - The Globe and Mail
Arq Inc Delays Commissioning of GAC Facility - TipRanks
An Overview of Arq's Earnings - Nasdaq
Argo's February 2025 Oil Production - The Globe and Mail
Arq Reports Third Quarter 2024 Results - ADVFN
Arq Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Analysts Are Optimistic We'll See A Profit From Arq, Inc. (NASDAQ:ARQ) - simplywall.st
Will Weakness in Argo Gold Inc.'s (CSE:ARQ) Stock Prove Temporary Given Strong Fundamentals? - simplywall.st
Fortis Law Partners Promotes Three Attorneys to Partner - The Malaysian Reserve
JPMorgan Chase & Co. Buys 103,877 Shares of Arq, Inc. (NASDAQ:ARQ) - Defense World
Arqit delivers quantum-safe protection enhanced by confidential computing - Arqit Quantum Inc. (ARQQ)
Geode Capital Management LLC Acquires 67,962 Shares of Arq, Inc. (NASDAQ:ARQ) - Defense World
Invesco Ltd. Increases Position in Arq, Inc. (NASDAQ:ARQ) - Defense World
Arq, Inc. (NASDAQ:ARQ) Stock Holdings Increased by Invesco Ltd. - The AM Reporter
28,428 Shares in Arq, Inc. (NASDAQ:ARQ) Bought by Cerity Partners LLC - Defense World
Arq, Inc. Scheduled to Release Q1 2025 Financial Results and Host Conference Call on May 7, 2025 - Nasdaq
Carbon Products Leader Arq Sets Q1 2025 Earnings Call: Key Details for Investors - Stock Titan
(ARQ) Proactive Strategies - news.stocktradersdaily.com
Member spotlight: IMS Arq. Sostenible - U.S. Green Building Council
Top 3 Materials Stocks Which Could Rescue Your Portfolio For April - NewsBreak: Local News & Alerts
Franklin Resources Inc. Has $2.23 Million Stock Position in Franklin FTSE Hong Kong ETF (NYSEARCA:FLHK) - Defense World
Corebridge Financial Inc. Buys 539 Shares of America’s Car-Mart, Inc. (NASDAQ:CRMT) - Defense World
Wellington Management Group LLP Takes $793,000 Position in Arq, Inc. (NASDAQ:ARQ) - Defense World
Arrowstreet Capital Limited Partnership Invests $301,000 in Arq, Inc. (NASDAQ:ARQ) - Defense World
American Century Companies Inc. Increases Stock Holdings in Arq, Inc. (NASDAQ:ARQ) - Defense World
Form PRE 14A Arq, Inc. For: Dec 31 - StreetInsider
Argo Acquires Gold and Silver Mineral Claims in Saskatchewan - TradingView
Sei Investments Co. Takes Position in Anterix Inc. (NASDAQ:ATEX) - Defense World
Slammed 29% Arq, Inc. (NASDAQ:ARQ) Screens Well Here But There Might Be A Catch - simplywall.st
How To Trade (ARQ) - news.stocktradersdaily.com
ArQule, Inc. Presents Results from Ongoing Phase 1 Dose Escalation Study of Its Reversible BTK Inhibitor, ARQ 531 - marketscreener.com
ArQule, Inc. Announces Preclinical Data on its Proprietary AKT Inhibitor, ARQ 092 - MarketScreener
ArQule, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017 - marketscreener.com
ArQule, Inc. Announces Top-Line Results of Phase 3 Clinical Study of Tivantinib in Hepatocellular Carcinoma in Japan - marketscreener.com
ArQule to Present Clinical Update for Miransertib in Rare Disease at the American Society of Human Genetics 2018 Annual Meeting - marketscreener.com
Arq Inc Stock (ARQ) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.79%
7.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):